News Release, October 8, 2018: The Australian Government will invest $1 million to improve recovery and rehabilitation and help stroke survivors back to work. The Government package includes $750,000 specifically designated for funding a clinical trial of the innovative Perispinal Etanercept Stroke Treatment in Australia. “The project will enable more Australians of working age who have had a stroke to access new innovative and cutting edge treatment options to aid their recovery.”

Perispinal etanercept for treatment of chronic post-stroke neurological dysfunction is a treatment method invented and developed by Edward Tobinick M.D., Medical Director and Founder of the Institute of Neurological Recovery.

More at this link: http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2018-hunt134.htm

Immediate neurological recovery after treatment at the Institute of Neurological Recovery, September 14, 2018, two years after stroke. Improvements noted in speech, aphasia, apraxia and walking within minutes after treatment at the INR in Boca Raton, Florida.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Immediate neurological recovery after treatment at the INR Boca Raton, August 13, 2018

Immediate neurological recovery after treatment at the INR Boca Raton, August 13, 2018, two years after a brainstem stroke. Improvements noted in chronic post-stroke pain, visual tracking and gait within minutes after treatment.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Rapid Improvement in Walking, Balance, Tone & Cognition 3 Years After Stroke

From Kentucky to the INR in Boca Raton, Florida. Published July 16, 2018.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Invited editorial by Edward Tobinick, MD, entitled, “Perispinal etanercept advances as a neurotherapeutic” published in Expert Review of Neurotherapeutics, on April 25, 2018.

Walking without a stick (cane) after treatment at the INR! Eddie and his family from Scotland, visiting the INR Boca Raton, on April 23, 2018.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

She has written an update on her progress! See it here!

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Patient and father, from Iceland, discusses improvements 2 years after stroke. The stroke happened at age 17. Improvements discussed include: spasticity, left neglect, walking, speech, fatigue, and improved ability to swallow.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Treatment at the Institute of Neurological Recovery in Boca Raton, Florida, March 6, 2018, twenty two months after stroke. Immediate improvements in aphasia, apraxia of speech, walking, etc.

Request a consultation today | Terms of Use & Disclaimer